4b ) and showed a trend towards potentially reduced potency developing in the 25 °C-stored vaccines after 2 weeks.
← all excerpts
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
1
—
—
4b ) and showed a trend towards potentially reduced potency developing in the 25 °C-stored vaccines after 2 weeks.